Dual Wnt and EGFR-MAPK dependency of BRAFV600E-mutant colorectal cancer

被引：3
|
作者：
Wang, Youzhen [1 ]
Palmer, Michael [1 ]
Jaeger, Savina [1 ]
Bagdasarian, Linda [1 ]
Qiu, Shumei [1 ]
Woolfenden, Steve [1 ]
Meyer, Ronald [1 ]
Yang, Guizhi [1 ]
Green, John [1 ]
Pan, Shifeng [2 ]
Liu, Jun [2 ]
Gao, Hui [1 ]
Cao, Z. Alexander [1 ]
Myers, Andrea [1 ]
McLaughlin, Margaret E. [1 ]
机构：
[1] Novartis Inst Biomed Res, Cambridge, MA USA
[2] Novartis Res Fdn, Genom Inst, San Diego, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2140
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Improvements in Clinical Outcomes for BRAFV600E-Mutant Metastatic Colorectal Cancer
    Morris, Van K.
    Bekaii-Saab, Tanios
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4435 - 4441
  • [2] A comprehensive overview of the molecular features and therapeutic targets in BRAFV600E-mutant colorectal cancer
    Gu, Ruiqi
    Fang, Hongsheng
    Wang, Renjie
    Dai, Weixing
    Cai, Guoxiang
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (07):
  • [3] Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
  • [4] An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
    Yaohua Xue
    Luciano Martelotto
    Timour Baslan
    Alberto Vides
    Martha Solomon
    Trang Thi Mai
    Neelam Chaudhary
    Greg J Riely
    Bob T Li
    Kerry Scott
    Fabiola Cechhi
    Ulrika Stierner
    Kalyani Chadalavada
    Elisa de Stanchina
    Sarit Schwartz
    Todd Hembrough
    Gouri Nanjangud
    Michael F Berger
    Jonas Nilsson
    Scott W Lowe
    Jorge S Reis-Filho
    Neal Rosen
    Piro Lito
    [J]. Nature Medicine, 2017, 23 : 929 - 937
  • [5] An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
    Xue, Yaohua
    Martelotto, Luciano
    Baslan, Timour
    Vides, Alberto
    Solomon, Martha
    Trang Thi Mai
    Chaudhary, Neelam
    Riely, Greg J.
    Li, Bob T.
    Scott, Kerry
    Cechhi, Fabiola
    Stierner, Ulrika
    Chadalavada, Kalyani
    de Stanchina, Elisa
    Schwartz, Sarit
    Hembrough, Todd
    Nanjangud, Gouri
    Berger, Michael F.
    Nilsson, Jonas
    Lowe, Scott W.
    Reis-Filho, Jorge S.
    Rosen, Neal
    Lito, Piro
    [J]. NATURE MEDICINE, 2017, 23 (08) : 929 - +
  • [6] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Jie Zhang
    Tsun-Wen Yao
    Rintaro Hashizume
    Sujatmi Hariono
    Krister J. Barkovich
    Qi-Wen Fan
    Michael Prados
    C. David James
    William A. Weiss
    Theodore Nicolaides
    [J]. Journal of Neuro-Oncology, 2017, 131 : 495 - 505
  • [7] COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS
    Zhang, Jie
    Hariono, Sujatmi
    Yao, Tsun-Wen
    Sidhu, Angadpreet
    Hashizume, Rintaro
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore P.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 60 - 61
  • [8] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Zhang, Jie
    Yao, Tsun-Wen
    Hashizume, Rintaro
    Hariono, Sujatmi
    Barkovich, Krister J.
    Fan, Qi-Wen
    Prados, Michael
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 495 - 505
  • [9] An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
    Xue, Yaohua
    Martelotto, Luciano
    Baslan, Timour
    Vides, Alberto
    Solomon, Martha
    Chadalavada, Kalyani
    DeStanchina, Elisa
    Nanjangud, Gouri
    Berger, Michael
    Lowe, Scott
    Reis-Filho, Jorge S.
    Rosen, Neal
    Lito, Piro
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [10] BRAFV600E-Mutant V600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
    Piercey, Oliver
    Tie, Jeanne
    Hollande, Frederic
    Wong, Hui-Li
    Mariadason, John
    Desai, Jayesh
    [J]. CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 215 - 229
12345